Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 536

1.

Decreased protein expression of candidate tumor suppressors TET3 and EPB41L3 in prostate cancers.

Mo HY, Son HJ, Choi EJ, Yoo NJ.

Pathol Res Pract. 2020 Jan 3:152815. doi: 10.1016/j.prp.2020.152815. [Epub ahead of print] No abstract available.

PMID:
31937425
2.

Inactivating mutations of tumor suppressor genes KLOTHO and DTWD1 in colorectal cancers.

Son HJ, Choi EJ, Yoo NJ, Lee SH.

Pathol Res Pract. 2020 Jan 3:152816. doi: 10.1016/j.prp.2020.152816. [Epub ahead of print] No abstract available.

PMID:
31924336
3.

Somatic mutation and loss of expression of a candidate tumor suppressor gene TET3 in gastric and colorectal cancers.

Mo HY, An CH, Choi EJ, Yoo NJ, Lee SH.

Pathol Res Pract. 2019 Dec 14:152759. doi: 10.1016/j.prp.2019.152759. [Epub ahead of print]

PMID:
31859118
4.

Somatic Mutations and Intratumoral Heterogeneity of Cancer-Related Genes NLK, YY1 and PA2G4 in Gastric and Colorectal Cancers.

Son HJ, Choi EJ, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Dec 11. doi: 10.1007/s12253-019-00785-z. [Epub ahead of print]

PMID:
31828582
5.

Mutation and Expression of a Candidate Tumor Suppressor Gene EPB41L3 in Gastric and Colorectal Cancers.

Son HJ, Choi EJ, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Dec 11. doi: 10.1007/s12253-019-00787-x. [Epub ahead of print]

PMID:
31828581
6.

Corrigendum to "DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers" [Pathol. Res. Pract. 214 (2018) 2075-2080].

Son HJ, Jo YS, Kim MS, Yoo NJ, Lee SH.

Pathol Res Pract. 2020 Jan;216(1):152749. doi: 10.1016/j.prp.2019.152749. Epub 2019 Nov 22. No abstract available.

PMID:
31761498
7.

Intratumoral heterogeneity of FLCN somatic mutations in gastric and colorectal cancers.

Son HJ, Choi EJ, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Nov 10. doi: 10.1007/s12253-019-00774-2. [Epub ahead of print] No abstract available.

PMID:
31709497
8.

Analysis of promoter mutation in CTNNB1 gene in solid and hematologic neoplasia.

Mo HY, An CH, Choi EJ, Yoo NJ.

Pathol Res Pract. 2019 Nov;215(11):152673. doi: 10.1016/j.prp.2019.152673. Epub 2019 Sep 26. No abstract available.

PMID:
31587824
9.

Somatic mutations of candidate tumor suppressor genes folliculin-interacting proteins FNIP1 and FNIP2 in gastric and colon cancers.

Mo HY, Son HJ, Choi EJ, Yoo NJ, An CH, Lee SH.

Pathol Res Pract. 2019 Nov;215(11):152646. doi: 10.1016/j.prp.2019.152646. Epub 2019 Sep 16. No abstract available.

PMID:
31570284
10.

Somatic mutations in long-non-coding RNA RMRP in acute leukemias.

Son HJ, Choi EJ, Yoo NJ, Lee SH.

Pathol Res Pract. 2019 Nov;215(11):152647. doi: 10.1016/j.prp.2019.152647. Epub 2019 Sep 16. No abstract available.

PMID:
31564567
11.

Mechanistic insights into the protective roles of polyphosphate against amyloid cytotoxicity.

Lempart J, Tse E, Lauer JA, Ivanova MI, Sutter A, Yoo N, Huettemann P, Southworth D, Jakob U.

Life Sci Alliance. 2019 Sep 18;2(5). pii: e201900486. doi: 10.26508/lsa.201900486. Print 2019 Oct.

12.

Residual modulation reduction in optical sectioning using a suitable spatial light modulator waveform.

Han JH, Yoo NW, Kim MH, Ju BK, Park MC.

Appl Opt. 2019 Aug 1;58(22):5883-5891. doi: 10.1364/AO.58.005883.

PMID:
31503934
13.

Promoter mutation analysis of PMS2 gene in solid tumors and acute leukemias.

Mo HY, Choi EJ, Yoo NJ, Lee SH.

Pathol Res Pract. 2019 Oct;215(10):152583. doi: 10.1016/j.prp.2019.152583. Epub 2019 Aug 8. No abstract available.

PMID:
31445717
14.

Promoter Mutation Analysis of Long-Non-coding RNA RMRP Gene in Solid Tumors.

Son HJ, Mo HY, Choi EJ, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Aug 17. doi: 10.1007/s12253-019-00723-z. [Epub ahead of print] No abstract available.

PMID:
31422524
15.

Somatic frameshift mutations of cancer-related genes KIF3C and BARD1 in colorectal cancers.

Son HJ, Choi EJ, Yoo NJ, Lee SH.

Pathol Res Pract. 2019 Oct;215(10):152579. doi: 10.1016/j.prp.2019.152579. Epub 2019 Aug 5. No abstract available.

PMID:
31400927
16.

Analysis of driver somatic mutations in heterotopia of pancreas, spleen, liver and adrenal tissues.

Jung SH, Jun SY, Shin S, Hong SM, Song SY, Yoo NJ, Chung YJ, Lee SH.

Pathol Res Pract. 2019 Jul;215(7):152461. doi: 10.1016/j.prp.2019.152461. Epub 2019 May 23. No abstract available.

PMID:
31146978
17.

Targeting the unfolded protein response in head and neck and oral cavity cancers.

Cole DW, Svider PF, Shenouda KG, Lee PB, Yoo NG, McLeod TM, Mutchnick SA, Yoo GH, Kaufman RJ, Callaghan MU, Fribley AM.

Exp Cell Res. 2019 Sep 1;382(1):111386. doi: 10.1016/j.yexcr.2019.04.007. Epub 2019 May 7. Review.

18.

Promoter Mutation Analysis of LEPROTL1 Gene in Acute Leukemias and Solid Tumors.

Mo HY, Kim MS, Chung NG, Yoo NJ, Lee SH.

Acta Haematol. 2019;141(4):214-215. doi: 10.1159/000494424. Epub 2019 Apr 3. No abstract available.

19.

Analysis of Promoter Mutation in Long Non-coding RNA NEAT1 in Acute Leukemias.

Mo HY, Jeon EH, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Jan 29. doi: 10.1007/s12253-019-00608-1. [Epub ahead of print] No abstract available.

PMID:
30694517
20.

Frameshift mutation of candidate tumor suppressor genes QK1 and TMEFF2 in gastric and colorectal cancers.

Mo HY, Jo YS, Yoo NJ, Kim MS, Song SY, Lee SH.

Cancer Biomark. 2019;24(1):1-6. doi: 10.3233/CBM-160559.

PMID:
30614793
21.

DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers.

Son HJ, Jo YS, Kim MS, Yoo NJ, Lee SH.

Pathol Res Pract. 2018 Dec;214(12):2075-2080. doi: 10.1016/j.prp.2018.10.005. Epub 2018 Oct 19. Erratum in: Pathol Res Pract. 2020 Jan;216(1):152749.

PMID:
30477644
22.

Promoter Mutation Analysis of ALDOA Gene in Solid Tumors and Acute Leukemias.

Son HJ, Choi EJ, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Apr;25(2):825-826. doi: 10.1007/s12253-018-0530-5. Epub 2018 Nov 14. No abstract available.

PMID:
30430423
23.

Absence of Promoter Mutation in TBC1D12 Gene in Solid and Hematologic Neoplasia.

Son HJ, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Oct;25(4):1675-1676. doi: 10.1007/s12253-018-0468-7. Epub 2018 Sep 10. No abstract available.

PMID:
30203167
24.

Polyphosphate Stabilizes Protein Unfolding Intermediates as Soluble Amyloid-like Oligomers.

Yoo NG, Dogra S, Meinen BA, Tse E, Haefliger J, Southworth DR, Gray MJ, Dahl JU, Jakob U.

J Mol Biol. 2018 Oct 19;430(21):4195-4208. doi: 10.1016/j.jmb.2018.08.016. Epub 2018 Aug 18.

25.

Promoter mutation in long non-coding RNA NEAT1 is not common in common solid cancers.

Kim MS, Jeon EH, Mo HY, Yoo NJ, Lee SH.

Pathol Res Pract. 2018 Nov;214(11):1912-1913. doi: 10.1016/j.prp.2018.07.013. Epub 2018 Jul 25. No abstract available.

PMID:
30097212
26.

Candidate Tumor Suppressor Gene EAF2 is Mutated in Colorectal and Gastric Cancers.

Jo YS, Kim SS, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2019 Apr;25(2):823-824. doi: 10.1007/s12253-018-0461-1. Epub 2018 Aug 7. No abstract available.

PMID:
30088132
27.

Intratumoral heterogeneity for frameshift mutations of TP53BP1 and MFN1 genes in colorectal cancers.

Choi EJ, Kim MS, Yoo NJ, Lee SH.

Pathol Res Pract. 2018 Sep;214(9):1514-1515. doi: 10.1016/j.prp.2018.07.024. Epub 2018 Jul 26. No abstract available.

PMID:
30082159
28.

Intratumoral Heterogeneity of RPL22 Frameshift Mutation in Colorectal Cancers.

Lee JH, An CH, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Jun 2. doi: 10.1007/s12253-018-0438-0. [Epub ahead of print] No abstract available.

PMID:
29860580
29.

Absence of KRAS hotspot mutations in endometriosis of Korean patients.

Kim MS, Yoo NJ, Hwang H, Kim MR, Lee SH.

Histopathology. 2018 Aug;73(2):357-360. doi: 10.1111/his.13524. Epub 2018 May 23. No abstract available.

PMID:
29604100
30.

Expressional analysis of APLNR, an essential gene for cancer immunotherapy, in colon and prostate cancers.

Yoo NJ, Kim MS, Lee JH, An CH, Lee SH.

Pathol Res Pract. 2018 Apr;214(4):599-600. doi: 10.1016/j.prp.2018.02.008. Epub 2018 Feb 22. No abstract available.

PMID:
29573866
31.

Intratumoral Heterogeneity for Inactivating Frameshift Mutation of CYB5R2 Gene in Colorectal Cancers.

Jo YS, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Mar 13. doi: 10.1007/s12253-018-0406-8. [Epub ahead of print] No abstract available.

PMID:
29532410
32.

Inactivating Frameshift Mutations of HACD4 and TCP10L Tumor Suppressor Genes in Colorectal and Gastric Cancers.

Jo YS, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Mar 12. doi: 10.1007/s12253-018-0409-5. [Epub ahead of print] No abstract available.

PMID:
29532408
33.

Somatic Mutations and Intratumoral Heterogeneity of MYH11 Gene in Gastric and Colorectal Cancers.

Jo YS, Kim MS, Yoo NJ, Lee SH.

Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):562-566. doi: 10.1097/PAI.0000000000000484.

PMID:
29517504
34.

A cross-linguistic comparison of category and letter fluency: Mandarin and English.

Eng N, Vonk JMJ, Salzberger M, Yoo N.

Q J Exp Psychol (Hove). 2019 Mar;72(3):651-660. doi: 10.1177/1747021818765997. Epub 2018 Mar 28.

PMID:
29512423
35.

Mutational intratumoral heterogeneity of a putative tumor suppressor gene RARRES3 in colorectal cancers.

Lee JH, An CH, Yoo NJ, Lee SH.

Pathol Res Pract. 2018 Apr;214(4):601-602. doi: 10.1016/j.prp.2017.12.011. Epub 2017 Dec 21. No abstract available.

PMID:
29496306
36.

Intratumoral heterogeneity for inactivating frameshift mutation of CUX1 and SIRT1 genes in gastric and colorectal cancers.

Jo YS, Kim MS, Yoo NJ, Lee SH.

Pol J Pathol. 2017;68(3):258-260. doi: 10.5114/pjp.2017.71534.

37.

Rare frameshift mutations of putative tumor suppressor genes CSMD1 and SLX4 in colorectal cancers.

Lee JH, An CH, Kim MS, Yoo NJ, Lee SH.

Pathol Res Pract. 2018 Feb;214(2):325-326. doi: 10.1016/j.prp.2017.12.001. Epub 2017 Dec 6. No abstract available.

PMID:
29258766
38.

PLAG alleviates chemotherapy-induced thrombocytopenia via promotion of megakaryocyte/erythrocyte progenitor differentiation in mice.

Lee HR, Yoo N, Jeong J, Sohn KY, Yoon SY, Kim JW.

Thromb Res. 2018 Jan;161:84-90. doi: 10.1016/j.thromres.2017.10.005. Epub 2017 Oct 10.

PMID:
29220692
39.

Intratumoral Heterogeneity of Somatic Mutations for NRIP1, DOK1, ULK1, ULK2, DLGAP3, PARD3 and PRKCI in Colon Cancers.

Choi EJ, Lee JH, Kim MS, Song SY, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Oct;24(4):827-832. doi: 10.1007/s12253-017-0297-0. Epub 2017 Aug 26.

PMID:
28844109
40.

Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.

Yeon SY, Jo YS, Choi EJ, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Jul;24(3):617-622. doi: 10.1007/s12253-017-0287-2. Epub 2017 Aug 12.

PMID:
28803425
41.

Frameshift mutation and loss of expression of PLK2, a serine/threonine kinase-encoding gene, in colorectal cancers.

Lee JH, Kim MS, Yoo NJ, Lee SH.

Pathol Res Pract. 2017 Aug;213(8):1019-1020. doi: 10.1016/j.prp.2017.06.011. Epub 2017 Jul 1. No abstract available.

PMID:
28698103
42.

Intratumoral Heterogeneity of Frameshift Mutations of GLI1 Encoding a Hedgehog Signaling Protein in Colorectal Cancers.

Lee JH, Song SY, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Jul;24(3):477-481. doi: 10.1007/s12253-017-0272-9. Epub 2017 Jun 29.

PMID:
28664474
43.

Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.

Park YG, Kang S, Kim M, Yoo N, Roh YJ.

Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1375-1383. doi: 10.1007/s00417-017-3672-3. Epub 2017 Apr 18.

PMID:
28421342
44.

Is Industry Funding Associated with Greater Scholarly Impact Among Academic Neurosurgeons?

Eloy JA, Kilic S, Yoo NG, Mcleod T, Svider PF, Baredes S, Folbe AJ, Couldwell WT, Liu JK.

World Neurosurg. 2017 Jul;103:517-525. doi: 10.1016/j.wneu.2017.03.110. Epub 2017 Apr 2.

PMID:
28377248
45.

TRIO Gene Encoding Trio Rho Guanine Nucleotide Exchange Factor Harbors Frameshift Mutations of in Gastric and Colorectal Cancers.

Choi EJ, Kim MS, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Jan;24(1):185-187. doi: 10.1007/s12253-017-0211-9. Epub 2017 Feb 21. No abstract available.

PMID:
28224356
46.

Inactivating frameshift mutation of putative tumor suppressor genes PLA2R1 and SRPK1 in gastric and colorectal cancers.

Lee JH, Jo YS, Kim MS, Yoo NJ, Lee SH.

Cancer Genet. 2017 Jan;210:34-35. doi: 10.1016/j.cancergen.2016.11.005. Epub 2016 Dec 21. No abstract available.

PMID:
28212809
47.

Low Frequent Mutation of ARHGAP35, a Candidate Tumor Suppressor Gene, in Gastric and Colorectal Cancers.

Choi EJ, Kim MS, Song SY, Yoo NJ, Lee SH.

Pathol Oncol Res. 2018 Jan;24(1):175-176. doi: 10.1007/s12253-017-0208-4. Epub 2017 Feb 7. No abstract available.

PMID:
28176259
48.

Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing.

Lee PJ, Yoo NS, Hagemann IS, Pfeifer JD, Cottrell CE, Abel HJ, Duncavage EJ.

Exp Mol Pathol. 2017 Feb;102(1):156-161. doi: 10.1016/j.yexmp.2017.01.012. Epub 2017 Jan 14.

PMID:
28093192
49.

Normal 2-Dimensional Strain Values of the Left Ventricle: A Substudy of the Normal Echocardiographic Measurements in Korean Population Study.

Park JH, Lee JH, Lee SY, Choi JO, Shin MS, Kim MJ, Jung HO, Park JR, Sohn IS, Kim H, Park SM, Yoo NJ, Choi JH, Kim HK, Cho GY, Lee MR, Park JS, Shim CY, Kim DH, Shin DH, Shin GJ, Shin SH, Kim KH, Kim WS, Park SW.

J Cardiovasc Ultrasound. 2016 Dec;24(4):285-293. doi: 10.4250/jcu.2016.24.4.285. Epub 2016 Dec 28.

50.

Mutational analysis of hypermutation-related POLE gene in acute leukemias and lymphomas.

Choi EJ, Kim MS, Yoo NJ, Lee SH.

Exp Hematol. 2017 Apr;48:39-40. doi: 10.1016/j.exphem.2016.12.005. Epub 2016 Dec 26. No abstract available.

PMID:
28034776

Supplemental Content

Support Center